CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2022	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 12,877,179	$ 15,215,285
Accounts receivable, net of allowance of $40,831 and $330,853 at December 31, 2022 and September 30, 2022, respectively	4,053,477	3,067,544
Inventories	477,014	602,244
Prepaid expenses and other current assets	924,682	1,058,056
Total current assets	18,332,352	19,943,129
Property and equipment, net	1,865,772	2,222,988
Other assets:
Deposits	98,987	98,997
Total assets	20,297,111	22,265,114
Current liabilities:
Accounts payable and accrued liabilities	3,056,123	3,621,751
Deferred revenue	273,880	563,557
Total current liabilities	3,330,003	4,185,308
Long term accrued liabilities	31,467	31,467
Warrants classified as a liability	7,777,200	5,139,400
Total liabilities	11,138,670	9,356,175
Commitments and contingencies
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively	0	0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2022 and September 30, 2022, 12,908,520 shares issued and outstanding as of December 31, 2022 and September 30, 2022	12,909	12,909
Additional paid in capital	305,492,756	305,399,008
Accumulated deficit	(296,343,460)	(292,500,088)
Applied DNA Sciences, Inc. stockholders' equity:	9,162,205	12,911,829
Noncontrolling interest	(3,764)	(2,890)
Total equity	9,158,441	12,908,939
Total liabilities and equity	20,297,111	22,265,114
Series A Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively	0	0
Series B Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively	$ 0	$ 0